Rosa Giuliani

Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide

C Praga, Jonas Bergh, Judith M. Bliss et al. · Journal of Clinical Oncology · 2005 · 182 citations · Full text

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

Evandro de Azambuja, Worta McCaskill‐Stevens, Prudence A. Francis et al. · Breast Cancer Research and Treatment · 2009 · 159 citations · Full text

Big 02-98, Breast Oncology, Oncology +8

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate

Marina Chiara Garassino, M. Vyas, Elisabeth G.E. de Vries et al. · Annals of Oncology · 2021 · 101 citations · Full text

Vaccination, Vaccine Safety, Preventive Medicine +11

ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe

Arnaud Bayle, Julia Bonastre, Dan Chaltiel et al. · Annals of Oncology · 2023 · 99 citations · Full text

Engineering, Medicine, Cancer Management +11

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

Rosa Giuliani, Virginie Durbecq, Angelo Di Leo et al. · European Journal of Cancer · 2007 · 59 citations

Metastatic Breast Cancer, Breast Oncology, Her-2/neu Gene Amplification +9